Abstract:Objective:The aim of this study is to verify the effect of magnetic field application on magnetic nanoparticles, distributed throughout the in vivo, normal rat liver, and observer resulting characteristic in the rat organs. Methods: Abdoninal exposurewas carride out through a midline abdominal incision. A cannula was inserted into the gastroduodenal artery. In the experimentalgroup,the left lateral lobe of the liver was exposed to the magnetic field for 30 minutes. Magnetic albumin nanoparticles containingadriamycin were injected into the hepatic artery (equivalent dosage of 0.5mg/kg of free Adriamycin). After the magnet was removed,the animal was immediately sacrificed. Administration of an equal dose of nanoparticles in the absence of a magnetic field served as acontrol. The target liver tissue, non- target liver tissue. heart, kidneys, lungs, spleens, stomach and small intestines were analyzed forI125 - counts. The histology of the liver tissue was examined. Results: In the experiment group, the radioactivity of the target sites was2.6 times higher than the non- target sites in the liver. In the control group,no statistical differences were found between that of the target sites and non-target sites. In both experimental and control group, the radioactivity of the heart,kidneys, lungs, spleen, stomach and small intestines was much lower than that of the liver (including target and non- targets sites). The radioactivity of the lungsin the experiment group decreased significantly, relative to the control group. In addition, 70～80％ of the injected radioactive nanoparticles collected in liver. The histology examination indicated that a large amount of nanoparticles accumulated in,and in somecases filled, the arterioles in the experimental group. In the control group,aggregation of nanoparticles was not found;there only nonaggreated, single nanoparticles dispersed in the hepatic sinus. Conclusions: In the presence of a magnetic field, magnetic albuminnanoparticles accumulated at a target site. The radioactivity of the target sites was 2.6 times higher than that of the non- target sites.70～80％ of the injected radioactivity dose collected in the liver. In the experiment group, the ratio of radioactivity at the heart, kidneys, spleen, lungs and intestines to the radioactivity at the liver target sites decressed significantly in comparison to the control group.This means that the overall percentage of harmful organ exposure to drugs in the experimental group was effectively reduced.

Magnetic targeted bio-distribution of dextran-magnetic LDH-fluorouracil transfer model in natural rats

Target distribution of magnetic nano-liposome loaded with 5-fluorouracil (MNLF) in rat with liver cancer

Pharmacokinetics Research on 5-Fluorouracil Magnetic Liposome Nanoparticles (FMLNP) in Rats

Target Distribution of Magnetic Albumin Nanoparticles Containing Adriamycin in Model of Transplanted Liver Cancer in Rats

Study on Angiogenesis-Targeting Peptide Modified Iron Oxide Nanoparticles Used in Local Magnetic Hyperthermia in Tumor-Bearing Nude Mouse Models

Study on the Targeting of Dextran Magnetic Carriers in the Rat Abdominal Skin Flap

Process Modeling of Ferrofluids Flow for Magnetic Targeting Drug Delivery

Determination of Fluorouracil in Rats Intervention with a DMF Transfer Model

[Targeting Therapy of Magnetic Doxorubicin Liposome in Nude Mice Bearing Colon Cancer].

Synthesis and Cell Imaging of a Near-Infrared Fluorescent Magnetic “Cdhgte–dextran-Magnetic Layered Double Hydroxide–Fluorouracil” Composite

Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer

In Vitro and in Vivo Evaluation of Targeting Efficiency of Adriamycin Hydrochloride Magnetic Microspheres.

Animal Experiment on Anti-Tumor Activity of Magnetic Nanocarrier and Doxorubicin with Target Simple External Magnetic Fields

Target Distribution of Magnetic Nanoparticle Containing Drug in Vivo and Its Therapeutical Efficiency for Liver Cancer

THE TARGET DISTRIBUTION OF MAGNETIC ALBUMINNANOPARTICLES CONTAINING ADRIAMYCIN IN NORMAL RAT LIVER

Targeted Drug Delivery for Liver Cancer of Rat Using Magnetic Chitosan Nanoparticles Absorbed with Doxorubicin

[Magnetic Drug Delivery System--adriamycin-carboxymethyl Dextran Magnetic Nanoparticles].

Targeting Therapy of Magnetic Doxorubicin Stealth Liposome on Human Gastric Cancer Xenografts in Nude Mice

Study on Effect of Magnetic Field Application on Targeting Distribution of Gal-HSA Magnetic Nanoparticles Containing Adriamycin

Study of Targeting Distribution of 5-Fu-mams in Pancreas under Magnetic Field

Observation the Magnetic Targeting Effect of Hyperthermia of Fe@C Nanocage-Loaded Chitosan Nanoparticles on Transplanted Rat Liver Cancer